In the news bulletins from the first days of October 2025, there was a line easy to scroll past between sanctions and strikes on oil refineries: for the first time in history, the Dutch government had invoked a law passed in 1952 to intervene in the affairs of a single company. The company is called Nexperia, and it makes nothing flashy—no processors, no memory. It makes parts you can pour into your palm: diodes, transistors, basic logic. They sell for fractions of a cent apiece. There are hundreds of them in a modern car, and Nexperia ships more than 110 billion such products a year.
What caught me was not the intervention itself, but its form. The state took control away from the owner—and yet did not acquire the factory. The minister gained the right to block decisions, while production remained physically in other hands: wafers are baked in Hamburg and Manchester, but cut, packaged, and tested mostly in Dongguan, southern China. The result was an arrangement that one Chinese political scientist described without any diplomacy: the Dutch thought they had taken the company, but they had taken only the office building.
So the question worth unraveling was this: what exactly can be taken from a company by legal act when its hands are in another country, and what happens when the other side answers with the same tool.
Wet beschikbaarheid goederen—the “Goods Availability Act”—appeared in 1952, shaped by the logic of the Cold War and postwar reconstruction. Its purpose was simple: in an emergency, the state had to be able to ensure supplies of critical goods, even if that meant intruding into someone else’s business. Professor of economic administrative law Pim Jansen of Erasmus School of Law explains that the law is short but grants sweeping powers—for instance, it explicitly allows the government to prohibit a company from changing production of critical goods without permission. It had never been used once since 1952.
The fact that this was its first launch defines half the story. The law has no case law, no settled interpretation, and nobody knows in advance how far its reach extends. Jansen frames the central uncertainty carefully: does “a serious deficiency in corporate governance” or “a risk of strategic dependency” qualify as the emergency circumstance described in the text—or is this economic protectionism beneath a legal signboard. The ministry, he says, provided little information, and the rationale for the decision remains opaque.
One important detail later lost in retellings: Minister of Economic Affairs Vincent Karremans signed the order on 30 September 2025, though it was publicly announced on 12 October. The reason was not bureaucratic sluggishness. 30 September was exactly the day the American 50% rule extended Entity List status from Nexperia’s Chinese owner, Wingtech, to Nexperia itself. It was also the day the company’s directors were already preparing a lawsuit, and the ministry managed to intervene first, before the owner could fire them and derail the process.
To understand why simple diodes warranted a separate government order, you have to look at the scale. By the company’s own fact sheet (August 2025): 2024 revenue of 2.06 billion dollars, an 8.9% market share, 12,500 employees, more than fifteen thousand product lines, over eight hundred new products a year. Five hundred patent families are registered in the Netherlands.
Nexperia grew out of NXP Semiconductors’ Standard Products division, itself spun off from Philips in 2006. In 2017, the business was sold to Chinese state funds JAC Capital and Wise Road; a year later, the funds organized a closed auction—open only to Chinese bidders. It was won by Wingtech, which was not itself a semiconductor manufacturer. Nexperia’s claimed leadership positions sit in such an unglamorous niche that AI analysis never writes about it: small-signal diodes and transistors, electrostatic-discharge protection devices, logic, power automotive MOSFETs.
Cars deserve a separate mention, because it was the automotive industry that turned this case from a legal matter into an industrial one. There are hundreds of these parts in a car, each worth pennies, and that is why nobody historically regarded them as a risk. S&P Global Mobility estimates that Nexperia holds about 5% of the global automotive market for discrete silicon components by value—but far more by unit volume. Formally, all of this is replaceable: standard discrete components built to JEDEC and AEC-Q101 specifications can be swapped for equivalents from Infineon, STMicroelectronics, ON Semiconductor, ROHM, or Renesas without redesigning anything.
But replacing that many part numbers is not like buying something in a shop. It means requalifying components, coordinating supplies, and validating functional safety across hundreds of product lines at once. They can be replaced, but until all the paperwork is cleared, the assembly line stops.
Beijing’s response came fast and landed on the arrangement’s only vulnerable point. On 4 October 2025, China’s Ministry of Commerce imposed export controls on all Nexperia facilities in China. The irony, later noted by the author of an analysis in The Diplomat: in a letter to parliament, the Dutch minister admitted that he had not expected such a response, because he was used to thinking of export controls as a non-proliferation tool. The Hague underestimated the extent to which export control had long ceased to be about weapons.
Then the asymmetry at the heart of the whole arrangement kicked in. More than a hundred billion products a year means Nexperia chips are already sitting in warehouses, moving through logistics pipelines, held in production inventory—but once packaged in Dongguan, they physically remain in China. Halt exports, and European car assembly—which has already written these parts into its plans—comes to a stop; Nexperia itself, meanwhile, goes nowhere. Reuters describes the sequence this way: on 26 October, the European side itself stopped shipping silicon wafers to Dongguan, citing non-payment, and the sides reached a stalemate: the Chinese facility sold down its accumulated inventory, while Europe sat without finished products.
It was specific assembly lines, not delivery schedules, that suffered. Nissan and Honda cut production, while Germany’s Bosch reduced working hours at its factories. A vice president at Seraph Consulting put the result for the auto industry bluntly: nobody had prepared for geopolitical disruptions, and nobody is prepared even now. In 2020, the industry swore it would never be caught out again; in 2025, it turned out that promise applied to complex chips, not cheap ones.
In November, the minister explained in an interview that he had seen intelligence indicating a plan to move production and expertise from Europe to China, taking people and intellectual-property rights with it, and that this would have left European industry completely dependent on China. Sources in The Hague were more specific: according to them, CEO Zhang Xuezheng planned to lay off 40% of the European workforce and shut down the research center in Munich, while chip designs and equipment settings had already been transferred to China from the British facility in Manchester.
In mid-November, the sides began to step back. On 10 November, the United States suspended its export measures for a year—as part of the Trump–Xi truce. On 19 November, The Hague suspended its own order under the 1952 law, citing constructive meetings and a “gesture of goodwill” from China. It looked like a resolution: the state came in and left, leaving behind nothing but a scandal.
The scandal, however, went to court. On 1 October, the Amsterdam Court of Appeal’s Enterprise Chamber—Ondernemingskamer, the chamber for corporate disputes—acting on a petition from Nexperia’s European directors themselves, issued the first of five urgent interim measures and barred the parties from publicly commenting on the proceedings. On 7 October, the court suspended the CEO and transferred Yuching’s shares, save for one single share, to an independent administrator.
That one share left behind is the neatest detail in the entire arrangement: it guarantees the formal owner the right to attend the general meeting and demand information, but strips it of a voting majority. Ownership remained. Control did not.
This is where the real division of labor comes into view. The ministry’s decision could be suspended with a diplomatic gesture. The court’s could not.
That is why, of the entire intervention, only the judicial proceeding ultimately survived—and why The Hague cannot be forced to undo what happened by simple pressure from Beijing. The author in The Diplomat directly calls the ministerial order perhaps superfluous and credits the Dutch legal system with two instruments: the doctrine of wanbestuur—“mismanagement,” under which a company is protected from its own directors, even if those directors created it—and the so-called polder model, in which the state, employers, and trade unions negotiate. The Chinese side, it seems, considered the latter a formality; tellingly, the owner did not renew the collective labor agreement with the unions—a gesture that, within the Dutch framework, reads as a refusal to negotiate in good faith.
On 11 February 2026, the chamber ruled that doubts about the propriety of management were justified, ordered an investigation, and appointed two investigators. The CEO’s suspension and the transfer of the shares to an administrator remain in effect until the end of the proceedings. In its official explanation, the court separately emphasizes that the shares have not been expropriated: they remain Yuching’s property; the temporary transfer means only the loss of a voting majority. It also says that the investigators’ report is not, in principle, published, and that an investigation usually takes more than half a year.
At the same time, two other proceedings are underway, and they are more interesting than the investigation itself. The first is about money. In December 2025, Nexperia terminated an intra-group loan and demanded more than 525 million dollars from Yuching, explaining that banks had cut off financing because of the change in control. Yuching replies that the change in control was created by Nexperia itself, and therefore it has no right to demand early repayment.
The second is a countersuit in China. In May 2026, Wingtech and Yuching filed a claim in a Dongguan court under China’s Anti-Foreign Sanctions Law, calling the Dutch measures discriminatory, and in August the court froze Nexperia’s assets and equipment worth 2.139 billion yuan—about 300 million dollars—until 2029. The claim is for 8 billion yuan, roughly 1.1 billion dollars. The symmetry is complete: Western national-security measures now meet mirror-image judicial proceedings in China.
There is another track as well—cassation. Both Yuching and the suspended CEO challenged all five urgent rulings, alleging, among other things, a violation of the right to a fair trial. In June 2026, the Advocate General of the Supreme Court of the Netherlands recommended dismissing the appeals: in his view, the chamber acted on legally sound grounds and gave sufficient reasons for its decisions. A recommendation is not a judgment, and no verdict date has been set, but this is the first independent view from above of the whole arrangement.
And in February 2026, the Telegraaf, citing sources, reported that Nexperia was looking for a way to part with its Chinese owner and that buyers had already lined up for the stake, but Wingtech refused to sell—the question, in the journalists’ words, is “extremely sensitive” in China. At the same time, something curious emerged: a similar case had quietly been resolved a year earlier. Another former Philips Semiconductor asset, Ampleon, with a Chinese owner and the same plan to move development to Shanghai, went through the same judicial chamber in 2024 in secret proceedings and ended in a settlement in 2025, under guarantees against technology leakage. The public learned about it in April 2026. Nexperia became loud because this time, it could not be kept quiet.
What remains of the practical side of the story is a set of numbers, and they do not look catastrophic for either side. The Chinese half has been cut off for good: since 1 October 2025, Nexperia has deconsolidated five Chinese legal entities in its reporting and, in every release, warns in a separate footnote that the figures do not apply to them. The European half survived and is growing: 300.3 million dollars in revenue in the first quarter of 2026, 355.6 million in the second—up 18.4% quarter on quarter, with positive profit and operating cash flow outside China.
Acting CEO Stefan Tilger promises that the largest shortages for European customers will end by the close of 2026, thanks to expanded assembly capacity in Southeast Asia; the Malaysian facility in Seremban is expanding, and at Semicon India 2026, Nexperia signed a memorandum with Tata Electronics to manufacture transistors on 300-millimeter wafers in Gujarat and assemble them in Assam.
The price of the whole affair has also become clearer—and it was mostly not measured in money. Wingtech is in financial trouble and risks delisting from the Shanghai Stock Exchange; European Nexperia has lost its Chinese half forever, but gained a new owner in the form of an independent administrator and a new geography of production. The Dutch state entered someone else’s company, exited it seven weeks later, and left behind a precedent: the 1952 law has now been used, and courts will define its limits.
The question that started it all remains without a neat answer. A legal act separates control from production, but it does not move factories: wafers in one country, packaging in another, and no decree can make two halves into one. Supporters of the intervention believe it succeeded precisely because it prevented not the relocation of production, but the transfer of chip designs and equipment settings—otherwise, the European half would today be looking for somewhere to build a factory from scratch rather than counting quarterly revenue. Critics in The Hague object: judging by the quiet Ampleon case, the same outcome could have been achieved through the courts alone, without the first-ever launch of a Cold War law. The Dutch Supreme Court will have to settle that dispute, and for now, the Advocate General’s recommendation is on the court’s side.